Skip to main content

Table 1 Severity scores for vascular anomalies

From: The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies

 

Score of 0

Score of 1

Score of 2

Score of 3

Score of 4

Score of 5

Score of 6

Bleeding/hemorrhage

Low-risk organs (skin and mucosa)

None

Mild without treatment

Moderate without transfusion

Severe, transfusion indicated

Very severe with hemodynamic instability

 

Fatal bleeding or death

High-risk organs (gastrointestinal tract and lungs)

None

 

Mild without treatment

 

Moderate without transfusion

Severe, transfusion indicated

Very severe or death

Thoracic lesions

Respiratory

None

 

Mild symptoms without treatment (PaO2 ≥ 80 Torr)

 

Chronic continuous symptoms, oxygen administration required (PaO2 ≥ 70 and < 80 Torr)

Severe symptoms, continuous drainage and surgery required (PaO2 ≥ 60 and < 70 Torr)

Very severe (PaO2 < 60 Torr, spO2 < 90%) or death

r

Cardiac

None

Very mildly symptomatic

Mildly symptomatic without treatment

Moderate, treatment required

Moderate or severe, oxygen administration required (EF < 50%)

Severe, with continuous intervention or surgery required, or heart failure (EF < 40%)

Very severe, fatal, or death

Abdominal lesions

 

None

Very mildly symptomatic

Moderately symptomatic without treatment

Severe, treatment required

Very severe with continuous intervention or surgery

 

Fatal or death

Bone lesions

 

None

Very mildly symptomatic

Moderately symptomatic without treatment

Severe, treatment required

Very severe with continuous intervention or surgery

 

Fatal or death

Cutaneous lesions

 

None

Very mildly symptomatic

Moderately symptomatic without treatment

Severe, treatment required

Very severe with continuous intervention or surgery

 

Fatal or death

Neurological symptoms

 

None

Very mildly symptomatic

Moderately symptomatic without treatment

Severe, treatment required

Very severe with continuous intervention or surgery

 

Fatal or death

Coagulation disorder and thrombocytopenia

 

Normal

Mild coagulation disorder or thrombocytopenia (Plt ≤100 × 103/μl)

Moderate coagulation disorder, low fibrinogen levels (≤100 mg/dl), or thrombocytopenia (Plt ≤50 × 103/μl)

Severe coagulation disorder, low fibrinogen levels (≤100 mg/dl), and thrombocytopenia (Plt ≤50 × 103/μl); treatment required

Very severe coagulation disorder, low fibrinogen levels (≤100 mg/dl) and thrombocytopenia (Plt ≤50 × 103/μl) with continuous intervention

 

Fatal or death

Nutritional status

 

Normal

Decreased oral intake or mild body weight loss (≤3%)

Moderately decreased oral intake or body weight loss (3–5%)

Poor oral intake or body weight loss (≥5%), required treatment

Very severe with continuous intervention

 

Fatal or death